s6y

6-K Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments

Filed
Period
Accession number
0001213900-26-111174

Documents

  1. REPORT OF FOREIGN PRIVATE ISSUER 6-K
  2. PRESS RELEASE, DATED OCTOBER 21, 2026, TITLED "PSYENCE BIOMED COMPLETES PSYLABS INVESTMENT AS IBOGAINE MILESTONES ARE MET." EX-99.1

On sec.gov